activistletters
Al Hartman Challenges Silver Star (SLVS) Over Distressed Sales, Cites $7.4M Value Loss and Puts Directors on Notice
Summary
Al Hartman criticized Silver Star’s recent sale of its Gulf Interstate property, claiming it was sold for just
activistletters
Findell Capital (9.5% Stake) Presses Oportun Financial (NASDAQ: OPRT) on Governance Failures, Nominates Warren Wilcox to Board
Summary
Findell Capital, the largest shareholder of Oportun Financial Corporation (roughly 9.5% stake), sharply criticizes the board’s governance
activistletters
Elliott Investment Management Challenges Phillips 66 (PSX) Board, Seeks Four Director Seats and Stronger Governance
Summary
Elliott Investment Management, a top-five shareholder in Phillips 66, called on shareholders to vote the Gold Card in support
activistletters
Servotronics (SVT): Save Servotronics Group Urges Shareholders to Elect New Board Amid Governance Failures and Strategic Alternatives Concerns
Summary
Paul L. Snyder III, leading a shareholder campaign, urged Servotronics shareholders to vote the WHITE proxy card in favor
activistletters
Impactive Capital Presses WEX (WEX) for Board Refresh, Governance Reform, and Accountability Following 250pt Lag vs Peer Corpay
Summary
Impactive Capital, a 7% shareholder in WEX Inc., announced its intention to vote AGAINST three incumbent directors—CEO/Chair
activistletters
Phillips 66 (PSX) Faces Elliott’s Push for Board Overhaul Amid Governance Failures and Refining Underperformance
Summary
The Elliott addendum (May 2, 2025) intensifies its proxy fight with Phillips 66. Elliott rebuts management’s claims about
activistletters
National Health Investors (NHI) Faces Land & Buildings’ Push for Board Change Amid NHC Lease Concerns and Governance Failures
Summary
The Land & Buildings (L&B) presentation dated May 2, 2025, continues its activist campaign against National Health
activistprofile
Starboard Value LP
I. Basics
Starboard Value LP is an investment adviser with a focused and fundamental approach to investing in publicly traded
activistcompany
Starboard Highlights Salesforce's (CRM)Operational Gains and Future Potential
Key Summary: On October 20, 2024, Starboard highlighted Salesforce Inc.'s significant improvements in operating margins and profitability in
activistcompany
Trium Capital Rejects Acelyrin (SLRN)-Alumis Merger, Urges Liquidation Instead
Key Summary: On April 29, 2025, Trium Capital opposes the Acelyrin-Alumis merger, citing undervaluation, flawed process, ignored alternatives, and conflicts
activistletters
Lyft (LYFT) Faces Engine Capital’s Push for Board Refresh Amid Value Destruction and Shareholder Dilution
Summary
The Engine Capital presentation (April 29, 2025) argues that Lyft has destroyed shareholder value, underperformed Uber and the market,
activistletters
Trium Capital Calls on Acelyrin (SLRN) Shareholders to Vote Against Alumis Merger, Citing Cash Discount and Conflicts
Summary
Trium Capital, a shareholder of Acelyrin, opposes the proposed merger with Alumis, arguing it significantly undervalues Acelyrin’s assets—
activistletters
Harley-Davidson (HOG) Faces H Partners’ “Free The Eagle” Campaign Targeting Zeitz and Long-Tenured Directors
Summary
The H Partners presentation (April 29, 2025) attacks Harley-Davidson’s leadership and board for severe underperformance and misleading claims.
activismweekly
13D weekly report - Apr 21, 2025 to Apr 25, 2025
Table of content
Value Base Ltd Opposes Poison Pill, Citing Shareholder Harm at Perion Network Ltd (PERI)
Key Summary: On
activistcompany
Galloway Capital Partners Considering Legal Action Against Weight Watchers International, Inc. (WW)
Key Summary: On April 25, 2025, Galloway Capital Partners (2.87%) opposed the company’s rumored Chapter 11, citing strong
activistletters
H Partners Challenges Harley-Davidson (HOG) Leadership, Seeks CEO Change and Stronger Governance via Withhold Campaign
Summary
H Partners, a 9.1% shareholder of Harley-Davidson, is urging shareholders to vote WITHHOLD on the re-election of CEO
activistletters
Keros Therapeutics (KROS) Faces ADAR1 Capital Letter Alleging Fiduciary Breaches Amid Strategic Alternatives Review
Summary
ADAR1 Capital Management, the largest shareholder of Keros Therapeutics, sent a letter to the board demanding that it waive
activistletters
Phillips 66 (PSX) Faces Elliott’s Criticism Over Peer Benchmarking, Governance, and Underperformance
Summary
The Elliott presentation (April 28, 2025) targeting Phillips 66 argues that management is misrepresenting performance through flawed metrics and
